Treatment Strategies of Colistin Resistance Acinetobacter baumannii Infections
Antibiotics · 06.05.2024 · 13 (5) · 423
DOI: 10.3390/antibiotics13050423 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 06.05.2024. Verfasst von Andria Papazachariou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine & Infectious Diseases, University General Hospital of Heraklion, 71500 Heraklion, Greece. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Acinetobacter baumannii has emerged as a pressing challenge in clinical practice, mainly due to the development of resistance to multiple antibiotics, including colistin, one of the last-resort treatments. This review highlights all the possible mechanisms of colistin resistance and the genetic basis contributing to this resistance, such as modifications to lipopolysaccharide or lipid A structures, alterations in outer membrane permeability via porins and heteroresistance. In light of this escalating threat, the review also evaluates available treatment options. The development of new antibiotics (cefiderocol, sulbactam/durlobactam) although not available everywhere, and the use of various combinations and synergistic drug combinations (including two or more of the following: a polymyxin, ampicillin/sulbactam, carbapenems, fosfomycin, tigecycline/minocycline, a rifamycin, and aminoglycosides) are discussed in the context of overcoming colistin resistance of A. baumannii infections. Although most studied combinations are polymyxin-based combinations, non-polymyxin-based combinations have been emerging as promising options. However, clinical data remain limited and continued investigation is essential to determine optimal therapeutic strategies against colistin-resistant A. baumannii.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine & Infectious Diseases, University General Hospital of Heraklion, 71500 Heraklion, Greece.
- Metropolitan Hospital, Neon Faliron, 18547 Athens, Greece.
ORCID-Profile: Andria Papazachariou, Renatos-Nikolaos Tziolos, Stamatis Karakonstantis, Petros Ioannou, Diamantis P Kofteridis
Zitieren
APA
Papazachariou, A., Tziolos, R. N., Karakonstantis, S., Ioannou, P., Samonis, G., & Kofteridis, D. P. (2024). Treatment Strategies of Colistin Resistance Acinetobacter baumannii Infections. Antibiotics, 13(5), 423. https://doi.org/10.3390/antibiotics13050423
Vancouver
Papazachariou A, Tziolos RN, Karakonstantis S, Ioannou P, Samonis G, Kofteridis DP. Treatment Strategies of Colistin Resistance Acinetobacter baumannii Infections. Antibiotics. 2024;13(5):423. doi:10.3390/antibiotics13050423
BibTeX
@article{Papazachariou2024,
author = {Papazachariou, Andria and Tziolos, Renatos-Nikolaos and Karakonstantis, Stamatis and Ioannou, Petros and Samonis, George and Kofteridis, Diamantis P},
title = {Treatment Strategies of Colistin Resistance Acinetobacter baumannii Infections},
journal = {Antibiotics},
year = {2024},
volume = {13},
number = {5},
pages = {423},
doi = {10.3390/antibiotics13050423}
}
EUVIMED